Loading…
Meghmani Organics (MOL)₹53.96−1.32%Pesticides & Agrochemicals
In the Jun 2026 quarter (consolidated), Meghmani Organics reported sales of ₹542 Cr, down 11.6% from Jun 2025, and net profit of ₹48.04 Cr, up 269.8% year on year. For the year to Mar 2026, sales were ₹2,174 Cr and net profit ₹29.03 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 379 | 352 | 410 | 414 | 543 | 569 | 553 | 614 | 577 | 509 | 474 | 542 |
| Expenses | 371 | 360 | 408 | 408 | 513 | 528 | 488 | 547 | 525 | 471 | 455 | 445 |
| Operating Profit | 8.03 | −8.03 | 2.01 | 6.02 | 31.14 | 41.17 | 65.25 | 67.24 | 52.21 | 38.15 | 20.08 | 98.36 |
| OPM % | 2.0% | −2.2% | 0.5% | 1.4% | 6.0% | 7.0% | 11.9% | 11.0% | 9.0% | 7.0% | 4.2% | 18.0% |
| Other Income | 12.01 | 10.01 | 8.99 | 9.01 | 11.99 | 9.01 | 14.01 | 17.01 | 28.03 | 15.01 | 37.04 | 11.99 |
| Interest | 12.98 | 26.96 | 1.99 | 10.98 | 25.95 | 12.98 | 18.96 | 28.96 | 23.95 | 17.97 | 19.97 | 12.98 |
| Depreciation | 22.99 | 22.99 | 22.97 | 23.01 | 24.96 | 29.97 | 28.98 | 29.96 | 29.97 | 29.98 | 28.97 | 30.01 |
| Profit before tax | −16.03 | −48.14 | −14.03 | −19.06 | −9.03 | 7.01 | 31.06 | 24.07 | 26.06 | 4.01 | 7.02 | 67.11 |
| Tax % | −3.0% | −19.9% | 25.1% | −12.9% | 1.0% | 159.1% | 35.1% | 48.0% | 56.1% | 179.1% | −12.0% | 28.1% |
| Net Profit | −14.99 | −37.99 | −17.99 | −17.01 | −8.99 | −4.01 | 20.01 | 12.99 | 11.99 | −4.01 | 8.01 | 48.04 |
| EPS (Rs) | −0.59 | −1.49 | −0.70 | −0.65 | −0.35 | −0.16 | 0.77 | 0.49 | 0.44 | −0.13 | 0.31 | 1.88 |
| Mar 2020 6m | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 699 | 1,635 | 2,497 | 2,554 | 1,566 | 2,080 | 2,174 | 2,102 |
| Expenses | 595 | 1,352 | 2,117 | 2,210 | 1,587 | 1,935 | 1,999 | 1,896 |
| Operating Profit | 105 | 284 | 381 | 343 | −19.08 | 145 | 177 | 209 |
| OPM % | 14.9% | 17.0% | 14.9% | 12.9% | −1.2% | 7.0% | 8.0% | 9.9% |
| Other Income | 130 | 29.99 | 102 | 114 | 36.99 | 42.01 | 96.11 | 92.07 |
| Interest | 17.98 | 10.98 | 8.99 | 65.89 | 45.95 | 68.85 | 91.86 | 74.87 |
| Depreciation | 21.98 | 50.93 | 62.98 | 76.92 | 91.89 | 108 | 119 | 119 |
| Profit before tax | 195 | 252 | 410 | 314 | −121 | 9.02 | 62.16 | 104 |
| Tax % | 23.0% | 26.1% | 26.1% | 24.1% | −12.0% | 212.1% | 54.0% | — |
| Exceptional items | 61.88 | 5.99 | 5.99 | 13.98 | 0.99 | 1.99 | 0.00 | — |
| Net Profit | 150 | 186 | 304 | 238 | −106 | −11.01 | 29.03 | 64.03 |
| EPS (Rs) | 29,884.30 | 37,255.17 | 11.95 | 9.34 | −4.16 | −0.41 | 1.12 | 2.50 |
| Dividend payout % | 17.0% | 18.9% | 11.9% | 14.9% | 0.0% | 0.0% | 0.0% | — |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 24.99 | 25.01 | 25.02 | 24.99 | 24.99 | 24.99 | 24.99 |
| Reserves | 960 | 1,147 | 1,438 | 1,643 | 1,499 | 1,487 | 1,517 |
| Borrowings | 264 | 268 | 499 | 823 | 835 | 829 | 725 |
| Other Liabilities | 409 | 534 | 835 | 707 | 679 | 743 | 751 |
| Total Liabilities | 1,657 | 1,973 | 2,798 | 3,198 | 3,039 | 3,084 | 3,018 |
| Fixed Assets | 480 | 632 | 909 | 1,163 | 1,149 | 1,571 | 1,498 |
| CWIP | 101 | 112 | 188 | 355 | 520 | 82.81 | 78.83 |
| Investments | 190 | 303 | 211 | 183 | 114 | 2.99 | 4.99 |
| Other Assets | 887 | 926 | 1,490 | 1,498 | 1,256 | 1,428 | 1,437 |
| Inventories | 304 | 376 | 640 | 653 | 518 | 600 | 530 |
| Trade receivables | 462 | 412 | 545 | 524 | 434 | 569 | 673 |
| Cash & equivalents | 9.03 | 21.06 | 11.03 | 33.11 | 20.06 | 31.09 | 25.06 |
| Total Assets | 1,657 | 1,973 | 2,798 | 3,198 | 3,039 | 3,084 | 3,018 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 22.07 | 334 | 65.19 | 204 | 251 | 66.19 | 223 |
| Cash from investing activity | 13.03 | −307 | −133 | −419 | −178 | 31.05 | −38.05 |
| Cash from financing activity | −25.99 | −13.99 | 57.97 | 234 | −84.99 | −90.99 | −190 |
| Net cash flow | 8.02 | 12.03 | −10.03 | 21.06 | −14.04 | 6.02 | −7.02 |
| Capex | 70.84 | 208 | 243 | 464 | 266 | 88.73 | 44.90 |
| Free cash flow | −48.83 | 124 | −176 | −258 | −13.96 | −19.95 | 178 |
| CFO / OP % | 48.0% | 143.0% | 42.0% | 84.0% | −1,328.0% | 49.0% | 142.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 242 | 93 | 80 | 76 | 102 | 100 | 114 |
| Inventory days | 270 | 151 | 160 | 157 | 184 | 172 | 144 |
| Days payable | 209 | 137 | 144 | 108 | 176 | 159 | 149 |
| Cash conversion cycle | 302 | 106 | 96 | 124 | 109 | 113 | 110 |
| Working capital days | 152 | 57 | 57 | 53 | 28 | 20 | 11 |
| ROCE % | — | 19.0% | 24.0% | 16.0% | −3.0% | 3.0% | 7.0% |
For the Jun 2026 quarter, Meghmani Organics reported sales of ₹542 Cr, down 11.6% year on year and net profit of ₹48.04 Cr, up 269.8% year on year. The operating margin was 18.0%.
Meghmani Organics' sales for the year to Mar 2026 were ₹2,174 Cr; over the last twelve months they were ₹2,102 Cr.
Net profit for the year to Mar 2026 was ₹29.03 Cr, and ₹64.03 Cr over the last twelve months. Earnings per share over the same trailing period were ₹2.50.
Meghmani Organics reported borrowings of ₹725 Cr at Mar 2026, against cash and equivalents of ₹25.06 Cr.
Cash from operations was ₹223 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹178 Cr.